Paeds Vivas · rheumatology-musculoskeletal-and-sports
Scleroderma, mixed connective-tissue disease and overlap syndromes: Viva
Branching clinical structured oral on the paediatric scleroderma, covering the distinction between the localised scleroderma (morphea) and the juvenile systemic sclerosis, the Zulian morphea classification with the linear subtype commonest, the PReS and ACR provisional criteria for the juvenile systemic sclerosis, the anti-U1-RNP overlap of the mixed connective-tissue disease, the methotrexate first-line therapy, the scleroderma renal crisis and the pulmonary hypertension that drive the prognosis.
On this page
Study tools
Target exams
This is a branching oral built to probe the reasoning that holds the localised and the systemic scleroderma and the overlap syndrome apart, and to expose the candidate who has memorised the headline without the organ-specific corners. The questions escalate from the framing to the classification, the organ screen, and the management, with the deliberate probes into the renal crisis and the pulmonary hypertension. [1]
Opening question: framing the problem
The examiner opens with the Raynaud phenomenon and the skin tightening and asks: how do you frame this problem in a single sentence, and what is your first priority? [1]
A strong answer names the juvenile systemic sclerosis as the working diagnosis, because the Raynaud phenomenon with the puffy hands and the proximal skin tightening is the classic presentation, and it distinguishes the systemic disease from the localised morphea that stays in the skin without the Raynaud. The first priority is the antibody panel, the nailfold capillaroscopy, and the baseline organ screen for the lung and the heart. [1][4]
Model answer. This child has the juvenile systemic sclerosis until proven otherwise, because the Raynaud phenomenon, the puffy hands and the proximal skin tightening together declare the multisystem disease. My first priority is the antibody panel, the nailfold capillaroscopy, and the baseline pulmonary function tests and the echocardiography to screen for the interstitial lung disease and the pulmonary hypertension. [1]
Probe one: the classification and the criteria
The examiner presses: what are the PReS and ACR provisional classification criteria, and how do you classify the cutaneous subtype? [2]
References8ShowHide
- [1]Foeldvari I, Pain CE Juvenile systemic sclerosis Best Pract Res Clin Rheumatol, 2026.PMID 41638996
- [2]Zulian F, Woo P, Athreya BH, Laxer RM, Medsger TA Jr, Lehman TJ, Cerinic MM, Martini G, Ravelli A, Russo R, Cuttica R, de Oliveira SK, Denton CP, Cozzi F, Foeldvari I, Ruperto N The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis Arthritis Rheum, 2007.PMID 17330294
- [4]Jindal AK, Patra P, Guleria S, et al. Clinical profile, long-term follow-up and outcome of juvenile systemic scleroderma: 25 years of clinical experience from North-West India Clin Exp Rheumatol, 2021.PMID 34251299
- [5]Di Pasquale G, Caione N, Di Berardino A, et al. Pulmonary manifestations of juvenile vs. adult systemic sclerosis: insights into pathophysiological and clinical features Pediatr Pulmonol, 2025.PMID 39545645
- [6]Zulian F, Athreya BH, Laxer R, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study Rheumatology (Oxford), 2006.PMID 16368732
- [10]Chevalier K, Bader-Meunier B, Kone-Paut I, Terrier B, Hachulla E, Mouthon L, Chaigne B, Costedoat-Chalumeau N Juvenile-onset mixed connective tissue disease: A multicenter retrospective cohort study Semin Arthritis Rheum, 2026.PMID 41412094
- [3]Foeldvari I, Klotsche J, Torok KS, et al. Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort J Scleroderma Relat Disord, 2019.PMID 35382144
- [11]John KJ, Sadiq M, George T, et al. Clinical and Immunological Profile of Mixed Connective Tissue Disease and a Comparison of Four Diagnostic Criteria Int J Rheumatol, 2020.PMID 32411251